Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

About 61% of women who had COVID-19 experienced hair loss afterward.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

COVID-19 may cause increased and quicker hair loss compared to other infections.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Thyroid function may influence hair loss after COVID-19.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Blood type affects COVID-19 infection rates differently in Europe and Africa.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Forensic medicine is crucial for justice and needs continuous innovation and technology integration.

Biologics for severe asthma have known side effects, but some new risks need more study.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

New therapies are being developed that target integrin pathways to treat various diseases.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

The document concludes that significant investment in agricultural innovation is necessary to achieve global food security and nutrition.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

COVID-19 may harm male fertility and damage the reproductive system.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.